Home/Filings/4/0001209191-22-061673
4//SEC Filing

Williams Timothy 4

Accession 0001209191-22-061673

CIK 0001347178other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 4:38 PM ET

Size

5.1 KB

Accession

0001209191-22-061673

Insider Transaction Report

Form 4
Period: 2022-12-15
Williams Timothy
SVP & General Counsel
Transactions
  • Sale

    Common Stock

    2022-12-15$7.01/sh8,000$56,07087,551 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.946 to $7.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001748392

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:38 PM ET
Size
5.1 KB